UniNeedle's biosensor continuously reads interstitial glucose and talks directly to your insulin pump, no fingersticks, no manual corrections, no guesswork.
People with Type 1 and insulin-dependent Type 2 diabetes make hundreds of glycemic decisions every day. UniNeedle closes the loop, so the system decides, and people live freely.
Sub-dermal micro-filament sensor. Applied in seconds, worn comfortably for 15 days.
Real-time bidirectional communication with any AID-compatible insulin pump.
iOS & Android companion app with trend arrows, alerts, and cloud-synced history.
On-device algorithm learns your personal insulin-to-carb ratio and correction factors over time.
Three integrated components form a seamless feedback cycle, sense, decide, deliver, refreshed every five minutes, around the clock.
Our biosensor binds glucose molecules in interstitial fluid and converts binding events into a real-time electrochemical signal, avoiding enzyme degradation common in first-gen CGMs.
A low-power ASIC on the transmitter filters, calibrates, and runs our predictive glycemic algorithm locally — results stay on your body, not a distant server.
Via Bluetooth LE, the device commands your AID pump in real time — micro-boluses for spikes, basal rate reductions for impending lows — continuously and automatically.
Our onboard 30-minute lookahead model suspends insulin delivery before a low occurs, not just after — reducing severe hypoglycemic events by over 70% in clinical trials.
Trending flat · Target range ✓
Post-lunch correction · 22 min ago
No intervention required
Your experience matters. This short survey helps us understand how people live with CGMs and insulin pumps today — and what UniNeedle needs to deliver tomorrow.
Your insights will directly shape the future of UniNeedle. We'll be in touch if we have follow-up questions.
Whether you're a clinician, researcher, patient advocate, or potential partner — we'd love to connect.